Human function needs a longitudinal record.
GHBI is building the intelligence layer that turns repeatable functional observations into structured change over time. We are seeking $1.0M in pre-seed financing to move from a working alpha/MVP to independent validation, controlled paid pilots and first recurring revenue.
Investment snapshot
A concise view of the company’s current stage and the milestones ahead.
Working alpha/MVP
Smartphone-first capture, 2D landmarks, basic metrics, reports, surveys and one longitudinal workflow.
$1.0M pre-seed
Planned 18–24 month operating program tied to validation, pilots, security and product milestones.
Pre-revenue
Founder-funded MVP and $0 institutional capital to date.
Patent pending
Multiple U.S. patent-pending applications covering core systems and methods.
60+ preliminary captures
25 surveys, 60+ landmarks, two early clinical settings and one longitudinal workflow.
Provider wedge
Begin with musculoskeletal and rehabilitation-focused design partners before larger deployments.
The problem and the opportunity
Healthcare digitized visits, records and images. Functional change remains difficult to standardize, compare and understand across time.
Signals live apart
Posture, mobility, patient-reported outcomes, records and context are rarely organized together.
Snapshots hide change
Single assessments document a moment but can miss progression, compensation and recovery.
Insight is hard to scale
Providers need repeatable capture and longitudinal comparison without losing professional judgment.
Healthcare investment focus
The $1.0M healthcare investment thesis centers on two complementary but distinct products: Global™ for providers and My Functional Journey™ for functional capture, tracking and individual experiences.
Provider web platform
Standardized capture, repeat assessment, structured reporting and longitudinal review. AI-assisted EMR interoperability is a planned capability within Global™; it is not active today.
Upcoming individual app
Guided check-ins, education, functional information, goals and change over time. It is not a diagnostic or treatment service.
What the working product organizes
The current foundation connects supported anatomical landmarks, quantitative measurements, regional organization, capture confidence and longitudinal review.
This visual is an explanatory recreation based on verified functions. It helps investors understand the product architecture without exposing patient data, confidential algorithms or known report-labeling defects.
Current evidence
The product has crossed from thesis into structured use, but the company is explicit about the evidence boundary.
Who pays and how GHBI intends to earn revenue
The commercial model is staged to match product maturity. Pricing remains a customer-discovery assumption until paid pilots validate willingness to pay.
Clinic SaaS
Planned recurring subscriptions for provider access, workflows, reporting and longitudinal review.
Enterprise licensing
Annual licenses plus implementation and integration services for larger organizations.
Consumer premium + research/API
Optional My Functional Journey premium features and controlled research or API access after governance matures.
Go-to-market: proof before scale
The next 18–24 months are designed to convert product capability into validated buyer value and recurring revenue.
Design partners
Recruit 3–5 clinics; refine capture, usability and provider value.
Validated MVP
Independent reliability and usability work; security and workspace hardening.
Paid pilots
Launch controlled deployments with explicit success, conversion and retention criteria.
Repeatable motion
First recurring revenue, enterprise pipeline and an integration-ready foundation.
Why GHBI can be defensible
The moat is intended to come from the combination of intellectual property, longitudinal structure and founder-developed workflow knowledge—not a generic AI wrapper.
Patent-pending portfolio
Multiple U.S. patent-pending applications cover core systems and methods. Legal diligence should review schedules, assignments and prosecution status.
Longitudinal structure
Repeatable capture plus context creates a functional timeline that can become more valuable as validated deployments grow.
Clinical workflow knowledge
Direct experience with more than 1,500 musculoskeletal patients informs what providers can realistically capture, review and use.
Team and execution record
Dr. Ricardo Alejandro Rodríguez Vázquez combines clinical practice, entrepreneurship, finance and multidisciplinary healthcare training.
Dr. Ricardo Alejandro Rodríguez Vázquez, D.C.
Palmer College of Chiropractic; MBA Accounting & Finance; M.Sc. Physiotherapy; M.Sc. Clinical Nutrition. Founder of two prior businesses, author of four books and operator of Chiropractic & Wellness Center, which generated more than $1 million in cumulative sales during its first four years.
Rasik Rodríguez · Magi Enterprises LLC
15+ years of software-engineering experience and a 15+ year working relationship with the founder. Scope, compensation, IP and security terms remain governed by company agreements.
Use of funds and risk discipline
The $1.0M round is tied to milestone creation, not unsupported scale claims.
Planned uses
- Product engineering and provider workspace
- Security, privacy and interoperability readiness
- Independent validation and controlled pilots
- Customer discovery, partnerships and go-to-market
- IP, legal and operating infrastructure
Primary risks and mitigation
- Validation: independent reliability, usability and outcomes work.
- Adoption: design partners, paid pilots and explicit success metrics.
- Regulatory: non-diagnostic scope, staged claims and counsel.
- Execution: milestone hiring, contracts, IP assignment and security controls.
Investor FAQ
Direct answers to the questions that should be resolved before a first meeting.
What exactly does GHBI do?
It structures repeatable functional measurements and context into a longitudinal timeline for provider and individual workflows.
Who is the initial buyer?
Clinic owners, clinical directors and innovation leads in musculoskeletal and rehabilitation-focused settings.
Is the product clinically validated?
No. The alpha/MVP is working; formal reliability, usability and clinical/functional validation remain planned milestones.
Is GHBI generating revenue?
No. GHBI is pre-revenue and founder-funded, with $0 institutional capital to date.
How is it different from an EMR?
EMRs organize visits, orders and records. GHBI is focused on repeatable functional measurement and change across time.
Does GHBI have active EMR integrations?
No named integration is currently claimed. Connectivity is an implementation and validation roadmap item.
Why can this team win?
Founder-market fit combines clinical experience, operating execution and a long-standing technical development relationship.
What is the next proof point?
Named design partners, a documented validation protocol, paid-pilot conversion and a current financial model.
Download and engage
The public pitch is designed for a first conversation. Cap table, financial model, patent schedules, contracts, security artifacts and detailed architecture belong in controlled diligence.